BioGeometry
PrivateLast Round
Series A
Oct 28, 2026
Total Funding Raised
$110M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
BioGeometry operates in Healthcare & Life Sciences and is based in Beijing. Its latest recorded funding round was a Series A round in October 2026.
BioGeometry is a biotechnology company that develops an AI-driven platform for programmable protein design and drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioGeometry Comparables
Compare BioGeometry with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alphabet Inc. | 71% | |
| Tencent | 70% | |
| ByteDance | 63% |
For institutional investors. Book with your work email.
BioGeometry Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 28, 2026 | ||||
| Series A | Jun 30, 2026 | ||||
| Pre Seed | Jun 19, 2024 | ||||
| Angel | Sep 1, 2022 |
For institutional investors. Book with your work email.
BioGeometry Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 星连资本 | Series A |
| Link-X Capital | Series A |
| China Science and Technology Industry Investment Management | Series A |
| Shengjing Jiacheng | Pre Seed |
| Shenzhen Dachen Caizhi Venture Capital Management | Series A |
| Jiangmen Ventures | Pre Seed |
| Shanghai International Venture Capital Equity Investment Fund Management Co., Ltd. | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 28, 2026
Led by China Science and Technology Industry Investment Management, Link-X Capital, and Shenzhen Dachen Caizhi.
- Jun 30, 2026
Led by China Science and Technology Industry Investment Management and others.
For institutional investors. Book with your work email.
BioGeometry Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BioGeometry's valuation, stock price, and market status.
Is BioGeometry a public or private company?
BioGeometry is a private company.
What is the current stock price of BioGeometry?
BioGeometry is a private company, so its shares have no public market price. Caplight tracks BioGeometry's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BioGeometry worth (valuation)?
Valuation information for BioGeometry is not publicly available.
Can I buy BioGeometry stock?
BioGeometry shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BioGeometry's last funding round?
BioGeometry's most recent funding round was Series A on October 28, 2026.
Who are the main investors in BioGeometry?
Key investors in BioGeometry include 星连资本, Link-X Capital, China Science and Technology Industry Investment Management, Shenzhen Dachen Caizhi Venture Capital Management, Jiangmen Ventures.
Will BioGeometry IPO soon?
No public IPO plans have been announced for BioGeometry.
How can I track BioGeometry secondary market activity?
Caplight tracks bids, offers, and trades in BioGeometry's shares on secondary markets.